
24 Oct 2022
Sareum Holdings (Buy) - FY22 results – in line and clinical trials set to begin in CY22
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Sareum Holdings (Buy) - FY22 results – in line and clinical trials set to begin in CY22
Sareum Holdings plc (SAR:LON) | 25.2 0.8 14.8% | Mkt Cap: 34.6m
- Published:
24 Oct 2022 -
Author:
Miles Dixon -
Pages:
5 -